Term
|
Definition
| Mucolytic by breaking disulfide bonds. Used in Cystic Fibrosis |
|
|
Term
|
Definition
| To treat excessive bleeding from heparin. Derived from fish sperm/testes |
|
|
Term
|
Definition
| Fibrinolytic. Activates FREE plasminogen so danger of Fibrinolytic state;From fetal renal cells;Expensive |
|
|
Term
|
Definition
| Inhibits platelet aggregation/vasoconstriction by blocking COX. Used in Polycythemia, PAD |
|
|
Term
|
Definition
| Beta-Blocker -> First line treatment for tremor. Avoid in asthma. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| System Decongestant. Alpha Adrenergic Agonist |
|
|
Term
|
Definition
| Direct Thrombin Inhibitor (Parenteral Anticoagulant) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Oral Anticoagulant. Antagonizes Vit K cofactor function of coagulation |
|
|
Term
|
Definition
| Act on stretch receptors to suppress cough. More effective than codeine. |
|
|
Term
|
Definition
| Inhibits platelet aggregation. Is a uricosuric (Oral) |
|
|
Term
| Captopril (Angiotensin converting enzyme inhibitor) |
|
Definition
| Avoid in asthma. May cause dry cough as an ADR. |
|
|
Term
|
Definition
| Erythropoeitin-like. Can treat Anemia, Myelofibrosis(Fibrous tissue replaces RBC stem cells). |
|
|
Term
| Potassium channel openers |
|
Definition
| Suppress Bronchoconstriction, hypersecretion, cough, and airway hyperactivity. |
|
|
Term
|
Definition
| Has longer t1/2, orally effective, and low affinity for other metals Vs. Deferoxamine. |
|
|
Term
|
Definition
Parenteral Anticoagulant. Binds/induces anti-thrombin III. Inhibits Factors X, II. Releases Tissue Factor
pathway inhibitor of Xa. |
|
|
Term
|
Definition
| Treats Thrombocytopenia (SC) by activating the thrombopoietin receptor to increase platelet count |
|
|
Term
|
Definition
| Parenteral anticoagulant. Recombinant Protein C (parenteral). A glycoprotein serine protease. |
|
|
Term
|
Definition
Decreases Neutrophils/Monocytes -> treat Polycythemia. Stimulate Hgb production -> treat
Myelofibrosis/Sickle Cell. Increases NO. Increases uric acid in blood. |
|
|
Term
|
Definition
| Treats Thrombocytopenipratroia (SC). Is IL-11 that stimulates stem cells to become megakaryocytes. |
|
|
Term
|
Definition
| Oral anticoagulant. Indandione derivative similar to warfarin. Severe hypersensitivity risk. |
|
|
Term
|
Definition
| Treats asthma by blocking 5-LPO therefore blocking leukotrine synthesis. CYP metabolized |
|
|
Term
|
Definition
| Treats asthma as Muscarinic Antagonist. Longer duration than Ipratropium. |
|
|
Term
|
Definition
| Inhibits platelets aggregation. Binds Glycoprotein receptors. Peptide(IV). |
|
|
Term
|
Definition
| Direct Thrombin Inhibitor (Oral anticoagulant Prodrug). Hepatotoxicity. |
|
|
Term
|
Definition
| Has shorter t1/2, only parenterallly effective, and higher affinity for other metals Vs. Defasirox. |
|
|
Term
|
Definition
| Parenteral Anti-coagulant. Very specific for blocking Xa via binding reversibly to anti-thrombin III. |
|
|
Term
|
Definition
| PDE5 inhibitor. 20mg treats Pulmonary Hypertention. 50 mg treats Erectile Dysfunction. |
|
|
Term
|
Definition
| Adrenergic Agonist for decongestion and bronchodilation |
|
|
Term
|
Definition
| Monoclonal antibody to decrease Mast Cell release of Leukotrines. |
|
|
Term
|
Definition
| ADH). Will vasoconstrict and increase BP for Cardiopulmonary Arrest.. |
|
|
Term
|
Definition
| Inhibits Platelet Aggregation by binding Purinergic receptors. Less ADRs/Faster Onset than Ticlopidine |
|
|
Term
|
Definition
| Parenteral anticoagulant. Low MW heparin. Induces anti-thrombin III. Affects Xa more than II. |
|
|
Term
|
Definition
| Fibrinolytic. Activates FREE plasminogen so danger of Fibrinolytic state. Synthesized. Longer t1/2. |
|
|
Term
|
Definition
| Inhibits Platelet Aggregation by binding Purinergic receptors. More ADRs. 8-11 days Onset |
|
|
Term
|
Definition
| Inhibits Platelet Aggregation and treats Pulmonary HTN via vasodilation. For Eisenmenger syndrome. |
|
|
Term
|
Definition
| Inhibits Platelet Aggregation. Binds Glycoprotein receptors. Non-peptide(IV). |
|
|
Term
|
Definition
| Local anesthetic that blocks stretch receptors at alveoli/bronchi to inhibit cough |
|
|
Term
|
Definition
| Fibrinolytic. Activates FREE plasminogen so danger of Fibrinolytic state. From bacteria. |
|
|
Term
|
Definition
| Parenteral anticoagulant. Used during heparin induced Thrombocytopenia and Hip Surgery prophylaxis. |
|
|
Term
|
Definition
| H2 Receptor block for treatment of Mild GERD. Less potent than a PPI. |
|
|
Term
|
Definition
| Inhibits platelets aggregation. Binds Glycoprotein receptors. Monoclonal Antibody(IV). |
|
|
Term
|
Definition
| Breaks down the DNA present in the thick fluid of mucous as seen in Cystic Fibrosis. |
|
|
Term
|
Definition
| Irrigates and smooths the irritated tissue in congestion |
|
|
Term
|
Definition
| Systemic Decongestant with low Therapeutic index |
|
|
Term
|
Definition
| Cough Suppressant. Morphine derivative with decreased analgesic activity. |
|
|
Term
|
Definition
| Treats bleeding by inhibiting plasminogen activation. (Opposite of fibrinolytics like streptokinase) |
|
|
Term
|
Definition
| Cough Suppressant. Morphine derivative with decreased analgesic activity. (Preferred to codeine) |
|
|
Term
|
Definition
| Inhibits synthesis of dihydrofolic acid. May lead to hemolytic anemia |
|
|
Term
|
Definition
| Oral expectorant. Induces excretion of fluid which lowers the mucuos viscosity. |
|
|
Term
|
Definition
| Prostacyclin(parenteral) for Pulmonary HTN. Longer t1/2 |
|
|
Term
|
Definition
| Prostacyclin(parenteral) for Pulmonary HTN. Shorter t1/2 |
|
|
Term
|
Definition
| Fibrinolytic(Alteplase). Activates plasminogen BOUND TO FIBRIN, so less danger of fibrinolytic state. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| PDE4 inhibitor, TNF blocker. Alters viscosity and increases blood flow in Sickle cell and PAD. |
|
|
Term
|
Definition
| Leukotrine Receptor blocker. For children >5. Shorter t1/2. For asthma. CYP metabolized |
|
|
Term
|
Definition
| Proton Pump Inhibitor. Used in treatment of GERD. |
|
|
Term
|
Definition
| Causes inflammation/bronchoconstriction/platelet aggregation/uterine contractions. Decreases IOP. |
|
|
Term
|
Definition
| Mast cell membrane stabilizer. Inhibits degranulation. |
|
|
Term
|
Definition
| Inhibits lipocortin to decrease Prostaglandins. Treats Pulmonary HTN, Congestion(2-3days), Asthma. |
|
|
Term
|
Definition
| Nasal Decongestant. Alpha adrenergic. Longest duration. |
|
|
Term
|
Definition
| Increases fetal Hgb production by inhibiting methylation of DNA and thus stops gamma -> beta globulin |
|
|
Term
|
Definition
| Deficiency -> Aplasia, Anemia, Angular Stomatitis/Cheilosis |
|
|
Term
|
Definition
| Treats bleeding by inhibiting plasminogen activation. (Opposite of fibrinolytics like streptokinase) |
|
|
Term
|
Definition
| Treats Thrombocytopenia (oral) Activates thrombopoietin receptor to increase platelets. Hepatotoxic |
|
|
Term
|
Definition
| Leukotrine Receptor blocker. For children >2. Longer t1/2. For asthma. CYP metabolized. |
|
|
Term
|
Definition
| PDE inhibitor(increases cAMP), Adenosine receptor block. For asthma. A Methylxanthine. |
|
|
Term
|
Definition
| Endothin-A(ET-A) receptor antagonist. For Pulmonary HTN and Eisenmenger syndrome. |
|
|
Term
|
Definition
| Antihistamine(Inverse agonist) and local anasthetic. For allergy. Sedative. |
|
|
Term
|
Definition
| Administering of gradually increasing allergen to build tolerance. Expensive and requires compliance. |
|
|
Term
|
Definition
| Carotene. Dietary supplement that can be used during COPD. |
|
|
Term
|
Definition
| Precursor from skin at sun exposure. Processed in liver/kidney. Used to help absorption of Calcium. |
|
|
Term
|
Definition
| Tocopherol/Ergocalciferol. A powerful antioxidant. |
|
|
Term
|
Definition
| A cofactor for Coagulation. Competes against warfarin. |
|
|
Term
|
Definition
| Thiamine. Decreased due to alcohol consumption. Deficiency => Wernicke-korsakoff dementia |
|
|
Term
|
Definition
| Riboflavin. Deficiency -> Aplasia, Anemia, Angular Stomatitis/Cheilosis |
|
|
Term
|
Definition
| Pyridoxine(PLP). Deficiency leads to anemia, and neurological symptoms. ADRs: Decreased Sensation |
|
|
Term
|
Definition
| Associated with B12 deficiency anemia. |
|
|
